cbdMD (YCBD) Return on Invested Capital (2020 - 2021)
cbdMD (YCBD) reported Return on Invested Capital of 0.29% for Q4 2021, down 20.0% on a YoY basis from 0.36% in Q4 2020, and down 244.56% sequentially from 0.08% in Q3 2021.
cbdMD (YCBD) Return on Invested Capital (2020 - 2021) Analysis & Trends
cbdMD (YCBD) has 2 years of Return on Invested Capital data on file, last reported at 0.29% in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.01% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 0.01% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 0.00% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.00% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.03% |
| 10 | cbdMD | 438,678.80 | -2.95 Mn | 3.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -0.29% |
| Sep 30, 2021 | -0.08% |
| Jun 30, 2021 | -0.06% |
| Mar 31, 2021 | -0.05% |
| Dec 31, 2020 | -0.09% |